Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04441411

Non Fusion Surgery in Adolescent Idiopathic Scoliosis Patients

The primary objective of the study is to monitor the effectiveness of a minimal invasive non-fusion double rod bipolar posterior spinal implant (Nemost growing domino) to correct the scoliotic curve in growing patients suffering from progressive adolescent idiopathic scoliosis (AIS) who have failed conservative treatment.

Recruiting

Interested in participating?

Request Info

Key information

Age range

10 year–17 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

AmsterdamUMC, location AMC

Amsterdam, North Holland, 1105AZ, Netherlands

Location status: Recruiting

Location contact

Dept of Orthopedics

CONTACT

+31(20)5662672

Dept of orthopaedics

CONTACT

+31(20)5662672

About this study

Scoliosis is a complex three-dimensional deformity of the spine, which occurs primarily in growing children and adolescents. In adolescent idiopathic scoliosis (AIS), the cause is unknown. Children with severe and progressive scoliosis, if left untreated, are at risk of rapid and severe spinal deformity progression, which can result in a decrease of pulmonary function, poor cosmetic result and poor quality of life.

Treatment options in AIS depend on curve severity and remaining growth potential, and include intensive brace treatment for smaller curvatures whereas surgical correction and spinal fusion is advocated for more severe curves. Growing rods are used for severe early infantile deformities or early onset scoliosis (EOS).

Bracing, by using a rigid plastic orthosis, is currently the primary therapy to prevent curve progression in mild curves up to 45 degrees and skeletal immature patients. Most braces are recommended to be worn for 18-23 hours per day during several years (until skeletal maturity has been reached). This may cause a high level of physical discomfort and emotional and psychological stress in these patients, and failure of brace treatment therefore is common.

Surgical therapy for AIS is recommended in severe progressive curvatures. Surgical treatment includes correction of the spinal curvature by using multisegmental screw fixation and posterior spinal fusion of the thoracolumbar spine. Complete posterior spinal fusion, however, lacks the possibilities for future adaptation of natural changes in spinal balance and posture.

Currently, growing rods systems are used as a posterior spinal implant to allow growth of the spine and thorax and limit progression of the scoliosis in young patients with early onset scoliosis. Growing rods systems are distractible spinal implants, with bipolar anchorage fixations to the upper and lower part of the spine, using posterior spinal instrumentation such as hooks and pedicle screws.

The Nemost growing system, developed by the EUROS Compagny, is a CE-marked commercial available medical device for the treatment of early onset neuromuscular or early onset idiopathic scoliosis. It is a non-fusion, growth enabling system with bipolar fixation intended to be used with a posterior spinal instrumentation.

It is hypothesized that the use of a minimal invasive non-fusion bipolar posterior spinal implant (Nemost growing domino) can both correct and brace the spine internally and adapt balans and or distraction as the idiopathic scoliosis patient grows.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adolescent idiopathic scoliosis ;
  • Primary Cobb angle greater than 30°;
  • Failed non-operative treatment defined as progression of the curve greater than 5° per year at any time;
  • Skeletally immature (Risser grade* ≤2 and Skeletal age of hand and wrist X-rays ≤14y);
  • In girl, either pre-menarchal or post-menarchal by no more than 1 year;
  • Age over 10 years;
  • Non rigid curve;
  • All Lenke type;
  • No previous spine surgery.

Exclusion criteria

  • Non-idiopathic scoliosis: musculoskeletal or neurologic conditions responsible for cause of the spine curvature (i.e. neuromuscular, congenital or syndromic scoliosis);
  • History of previous spine surgery;
  • Risser sign >2;
  • Disease or deformity likely to affect the stability of the device (i.e. inadequate anatomy of pedicles, trauma or tumor in fixation region, severe osteoporosis, bone destruction or poor bone quality);
  • Non-reductible scoliosis;
  • Known allergy or intolerance to one of the device material;
  • Acute or chronic infections, local or systemic;
  • Absence or insufficience of covering tissues;
  • Pathological obesity.

Treatment and study plan

NEMOST system

Device

Minimal invasive double rod posterior Non-Fusion Scoliosis Surgery

Primary outcomes

  1. Coronal balance (Correction of the primary curvature on radiograph

    Time frame: 2 years

    Cobb angle (degrees)

  2. T1-S1 length on radiograph

    Time frame: 2 years

    length (cm)

  3. instrument segment length on radiograph

    Time frame: 2 years

    length (cm)

  4. (Serious) Adverse Event

    Time frame: 2 years

    complications

  5. Sagittal balance (thoracic kyphosis, lumbar lordosis, proximal and distal junctional angle)

    Time frame: 2 years

    Cobb angle (degrees)

  6. Pelvic parameters (pelvic obliquity, sacral slope, pelvic incidence, pelvic tilt)

    Time frame: 2 years

    degrees

Secondary outcomes

  1. Vertebral rotation

    Time frame: 2 years

    scoliometer assesment

  2. Patient Reported Outcome (PRO

    Time frame: 2 years

    Scoliosis Research Society's-22 questionnaire

Study contacts

Contact information is provided by the study sponsor or research team.

AMC AmsterdamUMC

CONTACT

[email protected]

+31(0)205669111

BJ Van Royen, MD, PhD

CONTACT

[email protected]

+31(0)5662672

Sponsors and collaborators

Lead sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Other

Registry information

Official study title

Non Fusion Surgery in Adolescent Idiopathic Scoliosis Patients Using the Nemost-AIS System

Acronym: NEMOST-AIS

Important dates

Study start
2020
Primary completion
2026
Study completion
2028
First posted
Jun 22, 2020
Registry last updated
Jul 30, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.